A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy

Cancers - Switzerland
doi 10.3390/cancers12030745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Polymorphisms of a Disintegrin and Metalloproteinase With Thrombospondin Motifs 5 and Aflatoxin B1-Related Hepatocellular Carcinoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2015English

Models of Hepatocellular Carcinoma and Biomarker Strategy

Cancers
Cancer ResearchOncology
2010English

Oncogenic Wnt3a: A Promising Specific Biomarker in Hepatocellular Carcinoma

Hepatoma Research
2018English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Niclosamide Suppresses Migration of Hepatocellular Carcinoma Cells and Downregulates Matrix Metalloproteinase-9 Expression

Oncology Letters
Cancer ResearchOncology
2015English

DNA Methylation: Potential Biomarker in Hepatocellular Carcinoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2014English

Thymostimulin in Advanced Hepatocellular Carcinoma: A Phase II Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

New Systemic Treatments in Advanced Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2019English

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy